NCT05380349 2025-05-16
Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
Swedish Medical Center
Phase EARLY_PHASE1 Recruiting
Clinical Trials
3 trialsNCT04065087 2022-03-17
Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
Genexine, Inc.
Phase 1/2 Withdrawn
NCT03400917 2021-12-16
Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma
Aivita Biomedical, Inc.
Phase 2 Unknown